This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Lenovo’s ThinkPad, Razr+ singled out as infringing six Intellectual Ventures patents in US

By Melissa Ritti ( June 3, 2025, 15:29 GMT | Insight) -- Prolific patent litigant Intellectual Ventures flexed its portfolio might yesterday, accusing China’s Lenovo Group Limited of infringing six patents that trace their origins to fabless semiconductor company Transmeta, now defunct, and chipmaker Conexant, acquired by Synaptics in 2017. IV takes aim at a plethora of popular consumer electronics and asserts ownership of a variety of technological breakthroughs. The frequent legal foes will face off at trial later this year, in litigation which overlaps at least in part with IV’s newest complaint — unless a Texas federal judge first sides with Lenovo on its long-pending challenge to personal jurisdiction.Nonpracticing entities Intellectual Ventures I and Intellectual Ventures II (IV collectively), are banking on their acquisition of hundreds of former Transmeta patents to pay off....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections